2U3:FRA
Alcon AG
€64.74
arrow_downward
-1.28%(-0.84) 1D
Nov 13, 10:00:00 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2U3...
Open
€64.74
High
€64.74
Low
€64.74
Mkt. cap
30.74B
Avg. vol.
242.00
Volume
0.00
52-wk high
€73.96
52-wk low
€51.78
No. of employees
25K
Open
€64.74
High
€64.74
Low
€64.74
Mkt. cap
30.74B
Avg. vol.
242.00
Volume
0.00
52-wk high
€73.96
52-wk low
€51.78
No. of employees
25K
News stories
From web sources and news partners
Seeking Alpha
·
10 hours ago
Alcon Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:ALC) 2026-11-13
agefi.com
·
1 day ago
Alcon’s share price slump fails to deter analysts
Investing.com
·
1 day ago
Stifel cuts Alcon stock price target on 2027 growth concerns
Investing.com
·
1 day ago
Jefferies reiterates Alcon stock Buy rating, lowers estimates
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorHealth Care
IndustryMedical device
Websitealcon.com